ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir
in combination with chemoradiation for locally advanced inoperable
pancreatic cancer

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

Background and purpose Nelfinavir can enhance intrinsic radiosensitivity, reduce hypoxia and improve vascularity. We conducted a phase II trial combining nelfinavir with chemoradiotherapy (CRT) for locally advanced inoperable pancreatic cancer (LAPC). Materials and methods Radiotherapy (50.4 Gy/28...

書誌詳細
主要な著者:	Wilson, J, Fokas, E, Dutton, S, Hawkins, M, al., E
フォーマット:	Journal article
出版事項:	Elsevier 2016

類似資料

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
著者:: Wilson, J, 等
出版事項: (2017)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
著者:: Brunner, T, 等
出版事項: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
著者:: Brunner, T, 等
出版事項: (2008)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
著者:: Brunner, T, 等
出版事項: (2008)

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
著者:: Unaí Tupinambás, 等

New insights into the in silico prediction of HIV protease resistance to nelfinavir.
著者:: Dinler A Antunes, 等
出版事項: (2014-01-01)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
著者:: Chao Ying, 等
出版事項: (2008-02-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
著者:: Holyoake, D, 等
出版事項: (2016)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
著者:: Crosby, T, 等
出版事項: (2004)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
著者:: Anjali K. Gupta, 等
出版事項: (2007-04-01)

Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.
著者:: Pranav Kumar, 等
出版事項: (2010-03-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
著者:: Mukherjee, S, 等
出版事項: (2024)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
著者:: Zhongli Liu, 等
出版事項: (2022-08-01)

Pneumocephalus after the Treatment of an Inoperable Superior Sulcus Tumor with Chemoradiation
著者:: Ashley Albert, 等
出版事項: (2017-01-01)

The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors
著者:: André FA Santos, 等
出版事項: (2011-03-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
著者:: Mukherjee, S, 等
出版事項: (2018)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
著者:: Al-Assar, O, 等
出版事項: (2016)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
著者:: Sudeep Gupta, 等
出版事項: (2022-04-01)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
著者:: Fokas, E, 等
出版事項: (2013)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
著者:: Steffi Liebscher, 等
出版事項: (2017-02-01)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
著者:: E. P. Solov’eva, 等
出版事項: (2016-02-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
著者:: Christoph Driessen, 等
出版事項: (2016-03-01)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
著者:: V. B. Denisenko,, 等
出版事項: (2018-12-01)

Chemoradiation of pancreatic carcinoma
著者:: Erdinç Nayır, 等
出版事項: (2016-08-01)

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients
著者:: Jean-Guy Baril, 等
出版事項: (2003-01-01)

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
著者:: Camille Bono, 等
出版事項: (2012-07-01)

Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation
著者:: Hilario Yankey, MD, MBA, 等
出版事項: (2024-04-01)

Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer
著者:: N. V. Marinichenko, 等
出版事項: (2020-12-01)

Spectrophometric Determination of Nelfinavir Mesylate
著者:: K. Vanitha Prakash, 等
出版事項: (2006-01-01)

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study
著者:: Alison K. Yoder, 等
出版事項: (2021-07-01)

ACCELEREATED HYPERFRACTIONATED WITH UNEVEN CRUSHING DAILY DOSE WITH CHEMORADIATION TREATMENT OF INOPERABLE NON-SMALL CELL LUNG CANCER.
著者:: D. V. Gogolin, 等
出版事項: (2016-02-01)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
著者:: Léon Juan, 等
出版事項: (2006-07-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
著者:: Rosi Bissinger, 等
出版事項: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
著者:: Lenka Besse, 等
出版事項: (2023-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
著者:: Anna Gidari, 等
出版事項: (2022-12-01)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
著者:: Serena Veschi, 等
出版事項: (2018-09-01)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
著者:: Kang Young-Nam, 等
出版事項: (2010-06-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
著者:: Hill, E, 等
出版事項: (2016)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
著者:: Tinkl, D, 等
出版事項: (2009)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
著者:: Camacho Ricardo J, 等
出版事項: (2010-08-01)